Showing results (11-20 of 44) with videos related to
Sort By:
Pageof 5
Zhongguo Yao Li Xue Bao = Acta Pharmacologica Sinica|September 1, 1994
Pharmacokinetics of ofloxacin through three administration routesH T Zhuo, J Z Lu, X R Xia, et al.Journal of Virology|December 1, 1993
Two E2 binding sites (E2BS) alone or one E2BS plus an A/T-rich region are minimal requirements for the replication of the human papillomavirus type 11 originJ Z Lu, Y N Sun, R C Rose, et al.Journal of Applied Microbiology|January 4, 2018
Enhanced 1,3-propanediol production in Klebsiella pneumoniae by a combined strategy of strengthening the TCA cycle and weakening the glucose effectX Y Lu, S L Ren, J Z Lu, et al.Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|November 1, 1986
[Randomized clinical trial of cis-platinum diamminedichloride (PDD) in the treatment of hepatocellular carcinoma (HCC)]B H Yang, J Z Lu, Z Y Tang, et al.Cancer|March 1, 1991
Resection of the primary liver cancer of the hepatic hilusY Q Yu, Z Y Tang, Z C Ma, et al.The Analyst|May 1, 1997
Study of a lanthanide fluorescence system with a coupled reaction based on hemin catalysisX Y Zheng, J Z Lu, Q Z Zhu, et al.Journal of Cancer Research and Clinical Oncology|June 30, 1998
Improved long-term survival for unresectable hepatocellular carcinoma (HCC) with a combination of surgery and intrahepatic arterial infusion of 131I-anti-HCC mAb. Phase I/II clinical trialsZ C Zeng, Z Y Tang, K D Liu, et al.Cancer|January 1, 1993
Experience with liver resection after hepatic arterial chemoembolization for hepatocellular carcinomaY Q Yu, D B Xu, X D Zhou, et al.Cancer Immunology, Immunotherapy : CII|November 1, 1994
Human anti-(murine Ig) antibody responses in patients with hepatocellular carcinoma receiving intrahepatic arterial 131I-labeled Hepama-1 mAb. Preliminary results and discussionZ C Zeng, Z Y Tang, K D Liu, et al.Applied Optics|September 14, 2023
Numerical simulation and testing of laser-MIG hybrid-welding angle-structure sheetsC Y Cui, L Chen, J Yang, et al.Pageof 5